Effect of telemedicine intervention on hypoglycaemia in diabetes patients: A systematic review and meta-analysis of randomised controlled trials

Journal of Telemedicine and Telecare

Volumn 25, Issue 7, 2019, Pages 402-413

  Hu, Yuli ^a   Wen, Xiaohong ^b   Wang, Feifei ^b   Yang, Dongliang ^c   Liu, Shanshan ^a   Li, Pan ^a   Xu, Juling ^a  

^a HUZHOU UNIVERSITY   (China)

^b the First People's Hospital of Huzhou City   (China)

^c Higher Education District   (China)

Author keywords

diabetes mellitus; Hypoglycaemia; systematic review; telemedicine

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

BLOOD; BODY MASS; DIABETES MELLITUS; DIABETIC COMPLICATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; META ANALYSIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); TELEMEDICINE;

BLOOD GLUCOSE; BODY MASS INDEX; DIABETES COMPLICATIONS; DIABETES MELLITUS; GLYCATED HEMOGLOBIN A; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TELEMEDICINE;

EID: 85048869882     PISSN: 1357633X     EISSN: 17581109     Source Type: Journal    
DOI: 10.1177/1357633X18776823     Document Type: Article

References (57)

1. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes 2011; 26(2): 77–82.
2. Listed N. Introduction: the American Diabetes Association's (ADA) evidence-based practice guidelines, standards, and related recommendations and documents for diabetes care. Diabetes Care 2012; 35(Suppl1): S1–S2.
3. Ducoffe AR, Baehr A, Peña JC, Adverse drug event prevention. Am J Med Qual 2014; 16(2): 187–212.
4. Gerstein HC, Miller ME, Byington RP, Effects of intensive glucose lowering in type 2 diabetes. NEJM 2008; 358(24): 2545–2549.
5. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008; 300(8): 933–944.
6. Chan SP, Ji LN, Nitiyanant W, Hypoglycemic symptoms in patients with type 2 diabetes in Asia-Pacific-Real-life effectiveness and care patterns of diabetes management: the RECAP-DM study. Diabetes Res Clin Pract 2010; 89(2): e30–e32.
7. Seaquist ER, Anderson J, Childs B, Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and The Endocrine Society. J Clin Endocrinol Metab 2013; 98(5): 1845–1859.
8. American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005; 28(5): 1245–1249.
9. Oyer DS. The science of hypoglycemia in patients with diabetes. Curr Diabetes Rev 2013; 9: 195–208.
10. Unger J, Parkin C. Hypoglycemia in insulin-treated diabetes: a case for increased vigilance. Postgrad Med 2011; 123(4): 81–91.
11. Zoungas S, Patel A, Chalmers J, Severe hypoglycemia and risks of vascular events and death. NEJM 2010; 363: 1410–1418.
12. Cryer PE, Axelrod L, Grossman AB, Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009; 94(3): 709–728.
13. Harjutsalo V, Forsblom C, Groop PH. Time trends in mortality in patients with type 1 diabetes: nation-wide population-based cohort study. BMJ 2011; 343: d5364.
14. Weston PJ, Gill GV. Is undetectable autonomic dysfunction responsible for sudden death in type 1 diabetes mellitus? The ‘dead in bed’ syndrome revisited. Diabetic Med 1999; 16(8): 626–631.
15. Suys B, Heuten S, De Wolf D, Glycemia and corrected QT interval prolongation in young type 1 diabetic patients: what is the relation? Diabetes Care 2006; 29(29): 427–429.
16. Tsujimoto T, Yamamotohonda R, Kajio H, Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients. Diabetes Care 2014; 37(1): 217–225.
17. Holstein A, Plaschke A, Egberts EH. Incidence and costs of severe hypoglycemia. Diabetes Care 2002; 25(11): 2109–2110.
18. Zitkus BS. American Diabetes Association Standards of Medical Care in Diabetes. Nurse Practitioner 2014; 39(8): 22–32.
19. Miller KM, Foster NC, Beck RW, Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care 2015; 38(6): 971 978.
20. Garg SK, Hirsch IB. Self-monitoring of blood glucose. Int J Clin Pract 2011; 65(170): 1–9.
21. Spollett GR. Self-monitoring of blood glucose: an underutilized tool. Clin Diabetes 2010; 28(3): 127–129.
22. Moser EG, Morris AA, Garg SK. Emerging diabetes therapies and technologies. Diabetes Res Clinical Pract 2012; 97(1): 16–26.
23. WHO. Telemedicine: opportunities and developments in member states. Report on the second global survey on ehealth, Switzerland: World Health Organization (WHO), 2011.
24. Zhai Y, Zhu W, Cai Y, Clinical- and cost effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis. Medicine 2014; 93(28): e312.
25. Tao D, Or CK. Effects of self-management health information technology on glycaemic control for patients with diabetes: a meta-analysis of randomized controlled trials. J Telemed Telecare 2013; 19(3): 133–143.
26. Marcolino MS, Maia JX, Alkmim MB, Telemedicine application in the care of diabetes patients: systematic review and meta-analysis. PLOS One 2013; 8(11): e79246.
27. Rondags SM, de Wit M, Twisk JW, Effectiveness of HypoAware, a brief and partly web-based psychoeducational intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycemia: a cluster randomized controlled trial. Diabetes Care 2016; 39(12): 2190–2196.
28. Nimri R, Bratina N, Kordonouri O, MD-Logic overnight type 1 diabetes control in home settings: a multicentre, multinational, single blind randomized trial. Diabetes Obes Metab 2017; 19: 553–556.
29. Nicolucci A, Del Prato S, Vespasiani G. Optimizing insulin glargine plus one injection of insulin glulisine in type 2 diabetes in the ELEONOR study: similar effects of telecare and conventional self-monitoring of blood glucose on patient functional health status and treatment satisfaction. Diabetes Care 2011; 34(12): 2524–2526.
30. Charpentier G, Benhamou PY, Dardari D, The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care 2011; 34(3): 533–539.
31. Colomo N, Dominguez-Lopez M, Guerrero M, Cross-over randomized clinical trial to assess the effect of telecare on glycemic control in patients with type 1 diabetes and insulin-pump treatment: preliminary results. Diabetes Technol Therap 2013; 15: A102.
32. Del Prato S, Nicolucci A, Lovagnini-Scher AC, Telecare provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine—the ELEONOR study. Diabetes Technol Therap 2012; 14(2): 175–182.
33. Higgins J and Green SE. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011, p. S38. Available at: www.cochrane-handbook.org.
34. Garg SK, Shah VN, Akturk HK, Role of mobile technology to improve diabetes care in adults with type 1 diabetes: the remote-T1D study iBGStar in type 1 diabetes management. Diabetes Ther Res Treatment Ed Diabetes Rel Disord 2017; 8(4): 1–9.
35. Bajaj HS, Venn K, Ye C, Randomized trial of long-acting insulin glargine titration web tool (LTHome) versus enhanced usual therapy of glargine titration (iNNOVATE trial). Diabetes Technol Therap 2016; 18(10): 610–615.
36. Fountoulakis S, Papanastasiou L, Gryparis A, Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated diabetes mellitus patients with inadequate glycemic control: a randomized controlled study. Hormones 2015; 14(4): 632–643.
37. Esmatjes E, Jansà M, Roca D, The efficiency of telemedicine to optimize metabolic control in patients with type 1 diabetes mellitus: Telemed study. Diabetes Technol Therap 2014; 16(7): 435–441.
38. Bujnowska-Fedak MM, Puchała E, Steciwko A. The impact of telehome care on health status and quality of life among patients with diabetes in a primary care setting in Poland. Telemed J e-Health 2011; 17(3): 153–163.
39. Rossi MC, Nicolucci A, Lucisano G, Impact of the ‘diabetes interactive diary’ telemedicine system on metabolic control, risk of hypoglycemia, and quality of life: a randomized clinical trial in type 1 diabetes. Diabetes Technol Therap 2013; 14(8): 670–679.
40. Lim S, Kang SM, Shin H, Improved glycemic control without hypoglycemia in elderly diabetic patients using the ubiquitous healthcare service, a new medical information system. Diabetes Care 2011; 34(2): 308–313.
41. Zhou P, Xu L, Liu X, Web-based telemedicine for management of type 2 diabetes through glucose uploads: a randomized controlled trial. Int J Clin Experim Pathol 2014; 7(12): 8848–8854.
42. Gillani SW. Determining effective diabetic care: a multicentre longitudinal interventional study. Curr Pharma Des 2016; 22(42): 6469–6476.
43. Jansà M, Vidal M, Viaplana J, Telecare in a structured therapeutic education programme addressed to patients with type 1 diabetes and poor metabolic control. Diabetes Res Clin Pract 2006; 74(1): 26–32.
44. Lim S, Kang SM, Kim KM, Multifactorial intervention in diabetes care using real-time monitoring and tailored feedback in type 2 diabetes. Acta Diabetol 2014; 53(2): 189–198.
45. Kaur R, Kajal KS, Kaur A, Telephonic consultation and follow-up in diabetics: impact on metabolic profile, quality of life, and patient compliance. N Am J Med Sci 2015; 7(5): 199–207.
46. Zhou W, Chen M, Yuan J, Welltang—a smart phone-based diabetes management application improves blood glucose control in Chinese people with diabetes. Diabetes Res Clin Pract 2016(116)105–110.
47. Boaz M, Hellman K, Wainstein J. An automated telemedicine system improves patient-reported well-being. Diabetes Technol Therap 2009; 11(3): 181–186.
48. Shulman RM, O'Gorman CS, Palmert MR. The impact of telemedicine interventions involving routine transmission of blood glucose data with clinician feedback on metabolic control in youth with type 1 diabetes: a systematic review and meta-analysis. Int J Ped Endocrinol 2010; 2010(1): 1–9.
49. Lee JY, Lee SW, Nasir NH, Diabetes tele-monitoring reduces the risk of hypoglycemia during Ramadan: a pilot randomized controlled study. Diabetic Med 2014; 32(12): 1658–1661.
50. Wei NJ, Nathan DM, Wexler DJ. Glycemic control after hospital discharge in insulin treated type 2 diabetes: a randomized pilot study of daily remote glucose monitoring. Endocrine Pract 2014; 21(2): 115–121.
51. Croxson S. Hypoglycemia, cognition and the older person with diabetes. Pract Diabetes Int 2010; 27(6): 219–220.
52. Flodgren G, Rachas A, Farmer AJ, Interactive telemedicine: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2015, pp. CD002098.
53. Stratton IM, Adler AI, Neil HA, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS35): prospective observational study. BMJ 2000; 321(7258): 405–412.
54. Pal K, Eastwood SV, Michie S, Computer-based interventions to improve self- management in adults with type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2014; 37(6): 1759–1766.
55. Wood L, Egger M, Gluud LL, Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008; 336(7644): 601–605.
56. Kuenen JC, Borg R, Kuik DJ, Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients? Diabetes Care 2011; 34(8): 1843–1847.
57. Cui M, Wu X, Mao J, T2DM self-management via smartphone applications: a systematic review and meta-analysis. PLOS One 2016; 11(11): e016671.